Drug interactions with phenprocoumon and the risk of serious haemorrhage: a nested case–control study in a large population-based German database
Authors:
- 31 March 2011
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 67 (9) , 941-951
Abstract
Purpose Phenprocoumon is the most frequently used vitamin K antagonist in Germany. The aim of this study was to estimate the risk of serious bleeding as a result of the use of drugs with potential interaction with phenprocoumon. Methods We conducted a nested case–control study in a cohort of 246,220 phenprocoumon users in the German Pharmacoepidemiological Research Database. Cases were patients hospitalised for haemorrhage of different kinds. Ten controls were matched to each case by health insurance, birth year and sex using incidence density sampling. Odds ratios (OR) with 95% confidence intervals (CI) of the risk of serious bleeding associated with combined use of phenprocoumon and potentially interacting drugs versus phenprocoumon alone were estimated using conditional logistic regression analysis. Our analyses considered multiple risk factors, such as bleeding history, other comorbidities or co-medication. Results Our study included 2,553 cases and 25,348 matched controls. An increased risk of bleeding was observed for the combined use of phenprocoumon and clopidogrel vs phenprocoumon use alone (OR: 1.83, 95% CI: 1.41–2.36). Antibiotic drugs associated with an increased risk of haemorrhage in the population of phenprocoumon users included the group of quinolones with ORs ranging from 2.74 (95% CI: 1.80–4.18) for ciprofloxacin to 4.40 (95% CI: 2.45–7.89) for levofloxacin, amoxicillin plus clavulanic acid (OR: 2.99, 95% CI: 1.39–6.42) and cotrimoxazole (OR 3.57, 95% CI: 2.36–5.40). Among non-steroidal anti-inflammatory drugs (NSAIDs), ketoprofen and naproxen were associated with the highest risks. Conclusion Significantly elevated risks of major bleeding were mainly observed for drugs with known pharmacodynamic interaction with phenprocoumon, and less for drugs with possible pharmacokinetic interaction.Keywords
This publication has 62 references indexed in Scilit:
- Kidney Function Influences Warfarin Responsiveness and Hemorrhagic ComplicationsJournal of the American Society of Nephrology, 2009
- Anticoagulation After Cardioembolic StrokeArchives of Neurology, 2008
- Warfarin With Fluoroquinolones, Sulfonamides, or Azole Antifungals: Interactions and the Risk of Hospitalization for Gastrointestinal BleedingClinical Pharmacology & Therapeutics, 2008
- Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysisCanadian Medical Association Journal, 2008
- Pharmacology and Management of the Vitamin K AntagonistsChest, 2008
- Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleedingCanadian Medical Association Journal, 2007
- Adverse Drug Reaction-Related HospitalisationsDrug Safety, 2006
- Comparative Pharmacokinetics of Vitamin K AntagonistsClinical Pharmacokinetics, 2005
- Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patientsBMJ, 2004
- Clinically Important Drug Interactions with AnticoagulantsClinical Pharmacokinetics, 1996